STOCK TITAN

Fortrea Holdings SEC Filings

FTRE NASDAQ

Welcome to our dedicated page for Fortrea Holdings SEC filings (Ticker: FTRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Fortrea Holdings Inc. (NASDAQ: FTRE) files a variety of reports and disclosures with the U.S. Securities and Exchange Commission as a public company. This SEC filings page brings those documents together and adds AI-powered summaries to help readers understand the information that Fortrea provides through its regulatory filings.

Fortrea’s filings include current reports on Form 8-K, which disclose material events such as quarterly financial results, tender offers for senior secured notes, amendments to equity inducement award plans and changes in the composition of the board of directors or executive leadership. These 8-Ks often reference accompanying press releases that describe Fortrea’s revenues, net income or loss, adjusted financial measures, guidance and other operating details.

As a NASDAQ-listed issuer in the Professional, Scientific, and Technical Services sector, Fortrea also files annual reports on Form 10-K and quarterly reports on Form 10-Q. These periodic reports provide more comprehensive discussions of the company’s clinical development solutions, risk factors, financial statements and management’s analysis of results. Over time, they document how Fortrea manages its contract research organization activities and capital structure.

On this page, AI-generated highlights can help explain key points from lengthy filings, such as the implications of a debt tender offer, the nature of an inducement award plan, or the significance of board and executive changes. Users can also review information about securities registered under Section 12(b), including Fortrea’s common stock and rights to purchase Series A preferred stock.

In addition, this page provides access to filings that may relate to compensation arrangements, governance policies and other matters relevant to investors and analysts who follow FTRE. Real-time updates from the SEC’s EDGAR system, combined with AI summaries, are intended to make Fortrea’s regulatory disclosures easier to navigate and interpret.

Rhea-AI Summary

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC report beneficial ownership of 8,031,366.47 shares of Fortrea Holdings Inc. common stock, representing 8.9% of the class. The filing shows no sole voting or dispositive power and records shared voting power of 8,028,366.47 and shared dispositive power of 8,031,366.47, indicating the position is held collectively rather than by a single controlling party.

The filing identifies GS Group as a parent holding company and Goldman Sachs & Co. LLC as a broker/dealer and registered investment adviser and includes a joint filing agreement (Exhibit 99.1) and subsidiary identification (Exhibit 99.2). The statement certifies the securities were acquired and are held in the ordinary course of business and not to change or influence control of the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Fortrea Holdings director Peter M. Neupert reported two open-market purchases of the issuer's common stock: 30,000 shares on 08/08/2025 at a weighted average price of $6.79, and 32,500 shares on 08/11/2025 at a weighted average price of $6.26. The filing notes the trades were executed in multiple fills at price ranges of $6.69–$6.90 and $6.15–$6.39, respectively.

After these transactions the reporting person beneficially owned 98,132 shares. The Form 4 was signed by an attorney-in-fact on 08/11/2025. No derivative transactions or dispositions were reported on this form.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
quarterly report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.18%
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.18%
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of Fortrea Holdings (FTRE)?

The current stock price of Fortrea Holdings (FTRE) is $9.79 as of February 15, 2026.

What is the market cap of Fortrea Holdings (FTRE)?

The market cap of Fortrea Holdings (FTRE) is approximately 904.6M.
Fortrea Holdings

NASDAQ:FTRE

FTRE Rankings

FTRE Stock Data

904.60M
91.88M
0.5%
111.46%
11.57%
Biotechnology
Services-medical Laboratories
Link
United States
DURHAM

FTRE RSS Feed